Question 1

What are the main differences between LY353381 and tamoxifen?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. clinical trial (NCT00034125). Contact the study team or your healthcare provider for specific answers.

Question 2

How might the side effects of LY353381 compare to those of tamoxifen?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. clinical trial (NCT00034125). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of monitoring will I need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. clinical trial (NCT00034125). Contact the study team or your healthcare provider for specific answers.

Question 4

How will this trial fit into my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. clinical trial (NCT00034125). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any travel requirements for participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. clinical trial (NCT00034125). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. clinical trial (NCT00034125). Contact the study team or your healthcare provider for specific answers.

What this study is about